On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
MondayMar 13, 2017 5:00 pm

JinkoSolar Holding Co., Ltd. (NYSE: JKS) Starts Presentation at 29th Annual ROTH Conference

JinkoSolar (NYSE: JKS) distributes its solar products and sells its solutions and services to a diversified international utility, commercial and residential global customer base. JinkoSolar has built a vertically integrated solar product value chain, with an integrated annual capacity of 4.5 GW for silicon ingots and wafers, 3.7 GW for solar cells, and 6.5 GW for solar modules. For more information, visit the company’s website at www.jinkosolar.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of contributing journalists…

Continue Reading

MondayMar 13, 2017 5:00 pm

Cytokinetics, Inc. (NASDAQ: CYTK) Starts Presentation at 29th Annual ROTH Conference

Cytokinetics (NASDAQ: CYTK) is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company is developing small molecule drug candidates specifically engineered to increase muscle function and contractility. Cytokinetics’ lead drug candidate is tirasemtiv, a fast skeletal troponin activator (FSTA).  Tirasemtiv is the subject of VITALITY-ALS, an international phase 3 clinical trial in patients with ALS. Tirasemtiv has been granted FDA orphan drug designation and fast track status, as well as orphan medicinal product designation by the EMA. Cytokinetics is preparing for the potential commercialization of tirasemtiv in North America…

Continue Reading

MondayMar 13, 2017 4:30 pm

Cherokee, Inc. (NASDAQ: CHKE) Starts Presentation at 29th Annual ROTH Conference

Cherokee (NASDAQ: CHKE), based in California, markets, manages, and licenses fashion and lifestyle brands for apparel, footwear, home products, and accessories worldwide. The company owns or represents Cherokee, Liz Lange, Completely Me by Liz Lange, Hawk, Tony Hawk, Everyday California, Flip Flop Shops, Sideout, Sideout Sport, Carole Little, Saint Tropez-West, Chorus Line, All That Jazz, and other brands. The company currently maintains license and franchise agreements with leading retailers and manufacturers that span over 110 countries in 12,000 retail locations and digital commerce. For more information, visit the company’s website www.cherokeeglobalbrands.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication,…

Continue Reading

MondayMar 13, 2017 4:30 pm

BG Staffing, Inc. (NYSE: BGSF) Starts Presentation at 29th Annual ROTH Conference

BG Staffing (NYSE: BGSF) is a multi-division, publicly traded workforce solutions firm that operates through three segments: multifamily, professional, and commercial. The commercial segment provides temporary workers for various skilled and unskilled positions primarily to distribution, logistics, and call center customers. The multifamily segment offers front office and maintenance personnel to the multifamily housing industry on a temporary basis. The professional segment provides skilled temporary workers for IT customer projects, and finance and accounting needs. This segment also offers finance, accounting, and related support personnel. For more information, visit the company’s website at www.bgstaffing.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation…

Continue Reading

MondayMar 13, 2017 4:30 pm

EMCORE Corp. (NASDAQ: EMKR) Starts Presentation at 29th Annual ROTH Conference

EMCORE (NASDAQ: EMKR) provides advanced mixed-signal optics products that provide the foundation for today’s high-speed communication network infrastructures and leading-edge defense systems. The company’s optical chips, components, subsystems and systems enable broadband and wireless providers to continually enhance their network capacity, speed and coverage. EMCORE’s optical components and systems serve a broad array of applications including cable television, fiber-to-the-premise networks, telecommunications, wireless infrastructure, satellite RF fiber links, navigation systems and military communications. The company has fully vertically-integrated manufacturing capability through its Indium Phosphide (InP) wafer fabrication facility at its headquarters in Alhambra, California. For more information, visit the company’s website at www.emcore.com.…

Continue Reading

MondayMar 13, 2017 4:30 pm

Azure Power Global Ltd. (NYSE: AZRE) Starts Presentation at 29th Annual ROTH Conference

Azure Power Global (NYSE: AZRE) is an independent power producer. The company developed India’s first private utility scale solar project in 2009 and has been a developer, constructor and operator of utility scale, micro-grid and rooftop solar projects since its inception in 2008. With its in-house engineering, procurement and construction expertise and advanced in-house operations and maintenance capability, Azure Power manages the entire development and operation process, providing low-cost solar power solutions to customers throughout India. For more information, visit the company’s website at www.azurepower.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full…

Continue Reading

MondayMar 13, 2017 4:30 pm

Sorrento Therapeutics, Inc. (NASDAQ: SRNE) Starts Presentation at 29th Annual Roth Conference

Sorrento Therapeutics (NASDAQ: SRNE) is a biopharmaceutical company that focuses on the discovery, acquisition, development and commercialization of proprietary drug therapeutics for addressing unmet medical needs worldwide. The company’s primary therapeutic focus is oncology, including the treatment of chronic cancer pain, as well as developing therapeutic products for other indications, such as immunology and infectious diseases. It is developing resiniferatoxin, a non-opiate, ultra-potent, and selective agonist of the TRPV-1 receptor for intractable pain in end-stage disease. For more information, visit the company’s website at www.sorrentotherapeutics.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a…

Continue Reading

MondayMar 13, 2017 4:30 pm

Cempra, Inc. (NASDAQ: CEMP) Starts Presentation at 29th Annual ROTH Conference

Cempra (NASDAQ: CEMP) is a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases. Cempra's two lead product candidates are currently in advanced clinical development. Solithromycin has been evaluated in two phase 3 clinical trials for community-acquired bacterial pneumonia. Cempra is currently seeking approval for both intravenous and oral capsule formulations from the U.S. Food and Drug Administration and the European Medicines Agency. Solithromycin is also in a phase 3 clinical trial for uncomplicated urogenital urethritis caused by Neisseria gonorrhoeae or chlamydia. The company’s second product candidate, Fusidic acid, has completed enrollment…

Continue Reading

MondayMar 13, 2017 4:30 pm

Columbus McKinnon Corp. (NASDAQ: CMCO) Starts Presentation at 29th Annual ROTH Conference

Columbus McKinnon (NASDAQ: CMCO) designs, manufactures, and markets material handling products for various commercial and industrial end-user markets in the United States and internationally. The company offers material handling products, technologies, systems and services, which efficiently and ergonomically move, lift, position and secure materials and people. Key products include hoists, cranes, actuators, rigging tools, light rail work stations and digital power and motion control systems. The company sells its products to various industries such as manufacturing, power generation and distribution, utilities, wind power, warehouses, commercial construction, oil and gas exploration and refining, petrochemical, marine, ship building, transportation and heavy duty…

Continue Reading

MondayMar 13, 2017 4:30 pm

AxoGen, Inc. (NASDAQ: AXGN) Starts Presentation at 29th Annual ROTH Conference

AxoGen (NASDAQ: AXGN) is engaged in innovative surgical solutions for peripheral nerve injuries. AxoGen's portfolio of products includes Avance®Nerve Graft, AxoGuard® Nerve Connector, AxoGuard® Nerve Protector, and Avive™ Soft Tissue Membrane. Along with these core surgical products, the company also offers AxoTouch™ Two-Point Discriminator and AcroVal™ Neurosensory & Motor Testing System. These evaluation and measurement tools assist health care professionals in detecting changes in sensation, assessing return of sensory, grip, and pinch function, evaluating effective treatment interventions, and providing feedback to patients on nerve function. The AxoGen portfolio of products is available in the United States, Canada, the United Kingdom, and several European and international…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217